BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26065650)

  • 1. Recurrent CDKN1B (p27) mutations in hairy cell leukemia.
    Dietrich S; Hüllein J; Lee SC; Hutter B; Gonzalez D; Jayne S; Dyer MJ; Oleś M; Else M; Liu X; Słabicki M; Wu B; Troussard X; Dürig J; Andrulis M; Dearden C; von Kalle C; Granzow M; Jauch A; Fröhling S; Huber W; Meggendorfer M; Haferlach T; Ho AD; Richter D; Brors B; Glimm H; Matutes E; Abdel Wahab O; Zenz T
    Blood; 2015 Aug; 126(8):1005-8. PubMed ID: 26065650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations.
    Durham BH; Getta B; Dietrich S; Taylor J; Won H; Bogenberger JM; Scott S; Kim E; Chung YR; Chung SS; Hüllein J; Walther T; Wang L; Lu SX; Oakes CC; Tibes R; Haferlach T; Taylor BS; Tallman MS; Berger MF; Park JH; Zenz T; Abdel-Wahab O
    Blood; 2017 Oct; 130(14):1644-1648. PubMed ID: 28801450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New mutation in hairy cell leukemia.
    Robak T; Smolewski P
    Blood; 2015 Aug; 126(8):930-1. PubMed ID: 26294716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The unpredictable consequences of CDKN1B/p27Kip1 mutations in cancer.
    Borriello A; Bencivenga D; Della Ragione F
    Cell Cycle; 2015; 14(18):2865-6. PubMed ID: 26223878
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomics of Hairy Cell Leukemia.
    Tiacci E; Pettirossi V; Schiavoni G; Falini B
    J Clin Oncol; 2017 Mar; 35(9):1002-1010. PubMed ID: 28297625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.
    Maitre E; Bertrand P; Maingonnat C; Viailly PJ; Wiber M; Naguib D; Salaün V; Cornet E; Damaj G; Sola B; Jardin F; Troussard X
    Oncotarget; 2018 Jun; 9(48):28866-28876. PubMed ID: 29989027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia.
    Chung SS; Kim E; Park JH; Chung YR; Lito P; Teruya-Feldstein J; Hu W; Beguelin W; Monette S; Duy C; Rampal R; Telis L; Patel M; Kim MK; Huberman K; Bouvier N; Berger MF; Melnick AM; Rosen N; Tallman MS; Park CY; Abdel-Wahab O
    Sci Transl Med; 2014 May; 6(238):238ra71. PubMed ID: 24871132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia.
    Schnittger S; Bacher U; Haferlach T; Wendland N; Ulke M; Dicker F; Grossmann V; Haferlach C; Kern W
    Blood; 2012 Mar; 119(13):3151-4. PubMed ID: 22331186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
    Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
    Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
    Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
    Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
    Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
    Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G
    J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
    Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
    Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF V600E mutation in hairy cell leukemia: from bench to bedside.
    Falini B; Martelli MP; Tiacci E
    Blood; 2016 Oct; 128(15):1918-1927. PubMed ID: 27554081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.
    Maitre E; Tomowiak C; Lebecque B; Bijou F; Benabed K; Naguib D; Kerneves P; Cornet E; Viailly PJ; Arsham J; Sola B; Jardin F; Troussard X
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p27
    Bencivenga D; Caldarelli I; Stampone E; Mancini FP; Balestrieri ML; Della Ragione F; Borriello A
    Cancer Lett; 2017 Sep; 403():354-365. PubMed ID: 28687353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cyclin-dependent kinase inhibitor 1B mutation in Han Chinese women with premature ovarian failure.
    Wang B; Ni F; Li L; Wei Z; Zhu X; Wang J; Cao Y; Ma X
    Reprod Biomed Online; 2010 Aug; 21(2):212-4. PubMed ID: 20615757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of CDKN1B, a candidate tumor-suppressor gene, in refractory secondary/tertiary hyperparathyroidism.
    Lauter KB; Arnold A
    Kidney Int; 2008 May; 73(10):1137-40. PubMed ID: 18288099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
    Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.